Lantheus says CMS grants transitional pass-through reimbursement status for PYLARIFY TruVu effective Oct. 1

PUBT · 1d ago
Lantheus says CMS grants transitional pass-through reimbursement status for PYLARIFY TruVu effective Oct. 1
  • CMS granted Transitional Pass-Through payment status for PYLARIFY TruVu, effective Oct. 1, 2026.
  • Status enables separate Medicare reimbursement for the product in the hospital outpatient setting, supporting access and billing certainty.
  • CMS also assigned a permanent HCPCS code effective Oct. 1, 2026, facilitating provider billing and reimbursement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantheus Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609300830PRIMZONEFULLFEED9836896) on September 30, 2026, and is solely responsible for the information contained therein.